Assessing the frequency of Gastroesophageal Reflux Disease among Chronic Obstructive Pulmonary Disease Patients

Abstract

Background: A minimum of 170 million individuals worldwide are thought to have chronic obstructive pulmonary disease (COPD), a common lung illness marked by reversible airflow limitation and chronic inflammation of the airways. Recent research indicated that symptoms associated with gastroesophageal reflux disease (GERD) are more prevalent in individuals with COPD. Objective: Objective of the present study was to find out the frequency of GERD in COPD patients. Methodology: The study was conducted at a Rehman medical institute in Pakistan from January 2022 to June 2022, using a cross-sectional design. Data was collected from 160 COPD patients, who underwent a comprehensive clinical examination and history. All these patients were assessed for GERD through a frequency scale for the symptoms of GERD (F.S.S.G questionnaire) instead of endoscopy and PH assessment. Spirometry was performed on each patient, and the findings were analyzed by a fellow specialist. The study also determined the frequency of GERD in COPD patients. SPSS version 23 was used for data analysis. Results: The current cross-sectional study includes a total of 160 participants including both males and females selected through a purposive sampling technique. Among them, 63.75% were males and 36.24% were female participants. The overall prevalence of GERD among the participants was 45%. GERD was found in 31.94%, 40.27% and 16. 66% among moderate, severe, and very severe cases of COPD. Conclusion: The study findings indicate that GERD was found in 45% of individuals with COPD. This underscores the importance for healthcare providers to thoroughly assess COPD patients for GERD to prevent further complications and enhance their quality of life.